Georgia Clinic / CCT Research

Norcross, Georgia 30092-4544

0 studies enrolling now · 2 studies all time

What they study most

Respiratory Syncytial Virus, Seasonal Influenza

Studies at this site

• A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age — Completed
• A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults — Completed